Growth Metrics

Omeros (OMER) Property, Plant & Equipment (Net) Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Net) Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -13.32%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 17.12%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -10.19%
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 24.11%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 12.18%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 3.92%
10 Omeros 772.03 Mn 636.71 Mn 9.31 Mn -36.77%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -36.77%
Dec 31, 2025 -33.98%
Sep 30, 2025 3.61%
Jun 30, 2025 10.08%
Mar 31, 2025 34.04%
Dec 31, 2024 37.33%
Sep 30, 2024 12.93%
Jun 30, 2024 16.30%
Mar 31, 2024 35.13%
Dec 31, 2023 30.70%
Sep 30, 2023 -7.04%
Jun 30, 2023 -8.95%
Mar 31, 2023 -8.12%
Dec 31, 2022 -13.81%
Sep 30, 2022 0.87%
Jun 30, 2022 0.73%
Mar 31, 2022 -33.13%
Dec 31, 2021 -32.14%
Sep 30, 2021 -37.93%
Jun 30, 2021 -38.66%
Mar 31, 2021 -35.23%
Dec 31, 2020 -33.38%
Sep 30, 2020 -22.10%
Jun 30, 2020 -25.68%
Mar 31, 2020 -25.09%
Dec 31, 2019 -0.42%
Sep 30, 2019 50.28%
Jun 30, 2019 71.72%
Mar 31, 2019 115.23%
Dec 31, 2018 81.28%
Sep 30, 2018 41.18%
Jun 30, 2018 70.83%
Mar 31, 2018 71.28%
Dec 31, 2017 79.59%
Sep 30, 2017 48.01%
Jun 30, 2017 13.99%
Mar 31, 2017 35.30%
Dec 31, 2016 24.19%
Sep 30, 2016 49.26%
Jun 30, 2016 58.56%
Mar 31, 2016 23.52%
Dec 31, 2015 21.61%
Sep 30, 2015 -4.49%
Jun 30, 2015 -13.01%
Mar 31, 2015 -26.49%
Dec 31, 2014 -16.72%
Sep 30, 2014 -11.13%
Jun 30, 2014 -7.54%
Mar 31, 2014 -6.52%
Dec 31, 2013 -9.45%
Sep 30, 2013 38.98%
Jun 30, 2013 48.64%
Mar 31, 2013 45.73%
Dec 31, 2012 40.32%
Sep 30, 2012 -17.77%
Jun 30, 2012 -30.67%
Dec 31, 2011 -54.44%